Category: VITENSKAP: Nyheter, Informasjon og Studier

Resected Pancreatic Cancer

Dendritic Cell-Based Immunotherapy in Patients with Resected Pancreatic Cancer: A Promising Strategy for Preventing Recurrence

Discover the promising potential of dendritic cell-based immunotherapy for preventing recurrence in patients with resected pancreatic cancer. A groundbreaking phase I/II clinical trial demonstrates that this immunotherapy approach significantly improves
Cells

The Future of Cancer Therapy: Innovations in Immunotherapy

Bladder cancer is a type of cancer that starts in the cells of the bladder, the organ in the pelvis that stores urine. In the face of this challenge, medical
Immunotherapy for Cancer

Harnessing the Power of Immunotherapy for Cancer

Immunotherapy for Cancer
Rezidiv

Recurrance rate for Breast Cancer

Coping with recurrence can be challenging. Seek emotional support, connect with other breast cancer survivors, and maintain hope. Empower yourself with knowledge about breast cancer and stay proactive in managing
Dendritic Cell Therapy Bladder Cancer Statistics

Success rates of Dendritic Cell Therapy on Bladder Cancer Patients at Immucura

Bladder cancer is a type of cancer that starts in the cells of the bladder, the organ in the pelvis that stores urine. In the face of this challenge, medical
Esophageal cancer

The Impact of Dendritic Cell Therapy on Esophageal Cancer at Immucura

According to recent data from Immucura, the incidence of esophageal cancer remains considerable, with a substantial number of new cases diagnosed each year. In the face of this challenging reality,
Ta kontakt